Calcin-O DS740 mg

Calcin-O DS is a mineral (calcium) supplement, not a conventional therapeutic drug, and is primarily used to prevent or treat dietary calcium deficiency.

Established / Guideline-Supported Uses

• Calcium supplementation: Calcin-O DS is used as a source of elemental calcium in individuals with inadequate dietary intake or increased calcium requirements.
• Bone health support: Used as an adjunct to support bone mineralization in conditions such as osteopenia and osteoporosis, generally alongside vitamin D and, where prescribed, specific anti-osteoporotic therapy (e.g., bisphosphonates) — Calcin-O DS does not replace guideline-directed osteoporosis treatment.
• Increased physiological need: Pregnancy, lactation, growth in children/adolescents, and older age, when dietary intake is insufficient.

Adjunct / Commonly Cited Uses (Limited High-Quality Evidence)

• Adjunct calcium source in conditions associated with calcium loss (e.g., prolonged immobilization, certain metabolic bone disorders), used under medical supervision.
• Marketed claims of benefit for joint, muscle, or general "wellness" support are not supported by robust clinical evidence and should not be the basis for use.

Calcin-O DS should be used for calcium supplementation as advised by a physician or nutritionist; it is not a substitute for treatment of underlying bone or endocrine disease.

Calcium Orotate Dihydrate contains calcium combined with orotic acid (as the dihydrate salt), providing elemental calcium as its active mineral component. Each tablet strength provides a defined amount of elemental calcium per tablet; check the product label for the exact elemental calcium content, as this varies by brand and formulation.

Calcin-O DS is the dihydrate salt form of calcium orotate, an organic calcium salt in which calcium is bound to orotic acid (a compound involved in pyrimidine nucleotide metabolism). It is marketed as an oral mineral supplement rather than a prescription therapeutic agent.

Calcin-O DS is available in Bangladesh as an oral tablet, typically taken with meals, used to supplement dietary calcium intake and support bone mineral health.

Mineral (Electrolyte) Supplement — Calcium Supplement

Calcium Orotate Dihydrate provides elemental calcium, an essential mineral required for bone mineralization, neuromuscular function, cardiac conduction, blood coagulation, and intracellular signaling. Orotic acid, the counter-ion, is a naturally occurring pyrimidine precursor that has been proposed (based on limited evidence) to facilitate calcium transport across cell membranes, though this mechanism is not conclusively established in humans.

Once absorbed (primarily in the small intestine, an active vitamin D–dependent process supplemented by passive diffusion at higher intakes), calcium from Calcium Orotate Dihydrate is distributed to bone (the major reservoir, ~99% of body calcium), with the remainder circulating in plasma in ionized, protein-bound, and complexed forms that are tightly regulated by parathyroid hormone, calcitonin, and vitamin D.

Calcin-O DS tablets should be taken orally with food to enhance absorption and reduce gastrointestinal discomfort. If more than one tablet is prescribed per day, doses should ideally be spaced through the day (e.g., with different meals) rather than taken all at once, to improve absorption efficiency. Swallow tablets whole with a glass of water unless the product is labeled as chewable.

Calcin-O DS can reduce the absorption of several medicines when taken together, and can itself be affected by other drugs and substances:

• Tetracycline and fluoroquinolone antibiotics (e.g., doxycycline, ciprofloxacin): Calcin-O DS forms non-absorbable complexes with these antibiotics, reducing their absorption and efficacy. Separate dosing by at least 2–3 hours (antibiotic before, or several hours after, Calcin-O DS).
• Bisphosphonates (e.g., alendronate, ibandronate): Co-administration markedly reduces bisphosphonate absorption. Bisphosphonates should be taken on an empty stomach, at least 30–60 minutes before any calcium-containing product including Calcin-O DS.
• Levothyroxine: Calcin-O DS can reduce levothyroxine absorption; separate administration by at least 4 hours.
• Thiazide diuretics: Concurrent use with Calcin-O DS increases the risk of hypercalcemia due to reduced renal calcium excretion.
• Digoxin: Hypercalcemia arising from excessive calcium intake (including from Calcin-O DS) may increase the risk of digoxin-related cardiac arrhythmias.
• Vitamin D and calcium-containing antacids: Concomitant use increases calcium absorption and the risk of hypercalcemia if intake is excessive.

Calcin-O DS is generally well tolerated at recommended doses. Reported side effects include:

Common

• Abdominal bloating or distension
• Constipation
• Mild gastrointestinal upset (nausea, dyspepsia)

Less Common / With Excessive Intake

• Loss of appetite
• Increased thirst and increased urination
• Fatigue or weakness
• Weight loss
• Kidney stone formation with prolonged excessive intake (see Overdose Effects for signs of hypercalcemia)

Calcium requirements increase during pregnancy and lactation, and adequate calcium intake (from diet supplemented by Calcin-O DS where needed) is generally recommended. However, Calcin-O DS should be used during pregnancy and breastfeeding only if clearly needed, at doses that do not exceed recommended daily allowances, and under the guidance of a physician — excessive supplemental calcium intake should be avoided as it may increase the risk of hypercalcemia. A physician should be consulted before starting or continuing Calcin-O DS during pregnancy or lactation to weigh potential benefit against potential risk.

Calcin-O DS should be used with caution in the following situations:

• Renal impairment: Reduced ability to excrete calcium increases the risk of hypercalcemia; use only under medical supervision with monitoring.
• History of kidney stones: See Contraindications for active calcium-stone disease; even without contraindication, patients with a prior stone history should be monitored.
• Cardiac disease, particularly patients on digoxin: Hypercalcemia can precipitate arrhythmias (see Interactions).
• Sarcoidosis, hyperparathyroidism, malabsorption syndromes, or achlorhydria: These conditions can alter calcium absorption or predispose to hypercalcemia; use requires physician oversight.
• Prolonged high-dose use: Chronic excessive intake increases risk of hypercalcemia, hypercalciuria, and soft-tissue/vascular calcification; periodic monitoring of serum calcium is advisable with long-term use.

Calcin-O DS is a supplement and does not replace medical evaluation and treatment of underlying causes of calcium deficiency or bone disease.

Excessive intake of Calcin-O DS can lead to hypercalcemia. Symptoms of overdose/hypercalcemia may include nausea, vomiting, constipation, abdominal pain, excessive thirst, increased urination, confusion, muscle weakness, fatigue, and, in severe cases, cardiac arrhythmias or kidney impairment.

If overdose is suspected, seek immediate medical attention or contact a poison control center/emergency services. Do not attempt specific home treatment; management requires clinical assessment and may include measures directed by a physician to lower serum calcium.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pediatric Population

Use of Calcin-O DS in children should be guided by a pediatrician based on age-appropriate dietary reference intakes for calcium; safety and efficacy of specific Calcin-O DS tablet formulations have not been formally established in young children, and calcium-based dietary sources should be preferred where possible.

Elderly

Older adults commonly have increased calcium requirements (e.g., for osteoporosis prevention) but may also have reduced renal calcium clearance; use Calcin-O DS at the lowest effective dose with periodic monitoring, particularly if other risk factors for hypercalcemia are present.

Renal Impairment

Use with caution and medical supervision; see Precautions and Warnings.

Hepatic Impairment

No specific dose adjustment is established; no significant hepatic metabolism is expected for Calcin-O DS given its mineral nature.

Duration of Calcin-O DS use depends on the indication and is determined by the prescribing physician — ranging from short-term supplementation during periods of increased need (e.g., pregnancy) to longer-term use in chronic calcium-deficient states or as an adjunct in bone health management. Periodic reassessment of ongoing need and serum calcium status is advisable with prolonged use.

Minerals and Electrolytes > Calcium Supplements

Calcium Orotate Dihydrate supplies elemental calcium, which is absorbed in the small intestine (via active, vitamin D-dependent transport and passive paracellular diffusion) and incorporated into hydroxyapatite crystals during bone mineralization. Calcium ions also serve as essential second messengers and cofactors in neuromuscular transmission, cardiac contractility, and the coagulation cascade. Orotic acid, the accompanying organic acid, is proposed to enhance cellular calcium uptake by facilitating transport across cell membranes, though this adjunct mechanism is not definitively established through robust clinical trials.

Calcin-O DS may be used in children and adolescents to supplement dietary calcium intake when guided by a pediatrician, particularly during periods of rapid growth. However, formal safety and efficacy data for specific Calcin-O DS tablet products in the pediatric population are limited, and dietary sources of calcium should generally be prioritized. When supplementation is used, dosing should follow age-appropriate calcium reference intakes and physician guidance; Calcin-O DS is not recommended for self-directed use in children without medical supervision.